Simple Summary Non-small-cell lung cancer (NSCLC) accounts for approximately 85% of
all lung cancers, and the postoperative survival of early-stage NSCLC patients remains …

Serum biomarkers provide valuable information about the diagnosis and prognosis of a
wide variety of malignant tumors. Despite the identification of several useful serum …

BACKGROUND: Therapeutic possibilities for non-small cell lung cancer (NSCLC) have
considerably increased during recent decades. OBJECTIVE: To summarize the prognostic …

Background The roles of carcinoembryonic antigen (CEA), cytokeratin 19 fragments
(CYFRA21-1) and neuron-specific enolase (NSE) in metastases occurrence and poor …

Background The optimal treatment of stage I non–small-cell lung carcinoma is subject to
debate. The aim of this study was to compare overall survival and oncologic outcomes of …

In the last decade, proteomic analysis has become an integral tool for investigation of tumor
biology, complementing the genetic analysis. The idea of proteomics is to characterize …

Background Serum CYFRA 21–1 is one of the most important serum markers in the
diagnosis of non-small cell lung cancer (NSCLC), especially squamous-cell carcinoma …

The role of serum CYFRA 21-1 level in patients with non-small cell lung cancer (NSCLC)
remains to be defined. To re-evaluate the impact of serum CYFRA 21-1 in NSCLC survival …

Rationale and Objectives Lung adenocarcinomas (LADC) containing high-grade subtypes
have a poorer prognosis. And some studies have shown that high-grade subtypes have …

Abstract Backgroud: Keratin 19 (KRT19) is the intermediate filament that constitutes the
cytoskeleton and regulates cell-cycle and cell death. Objective: We aimed to assess whether …